IP Library Granted Patent US 11,105,795
Granted Patent B2
US 11,105,795 · App. 16/242,683 · Granted Aug 31, 2021

Methods and compositions for simulation of the dermal compartment

Inventors: James W. Winkelman (Chestnut Hill, MA); Martin E. Schmieg (Marblehead, MA)
Assignee: ClearIt, LLC
G01N33/5044C12N5/0656C12N2503/04C12N2503/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,105,795
App. No.
16/242,683
Granted
Aug 31, 2021
Kind
B2
Abstract

Methods and compositions for simulating a dermal compartment of skin are disclosed. In one aspect of the invention, methods of producing such a skin model include the steps of admixing a collagenous protein source, a blood protein source, and dermal cells in an aqueous carrier, and then allowing the resulting mixture to solidify to produce a gel. In one technique, at least a portion of the mixture, e.g., the collagenous protein source is first heated and then cooled to induce gelation. For example, the mixture can be heated to at least 50 degrees C. and then cooled to temperature below 5 degrees C. to induce gelation.

Claims (26)

1. A method for simulating the composition of a dermal compartment, comprising admixing a collagenous protein source, an anticoagulant-treated blood plasma, and dermal cells in an aqueous carrier, and allowing the resulting mixture to solidify to produce a gel,

wherein said gel is transparent through a depth of 2 cm.

2. The method of claim 1 wherein at least a portion of the mixture is first heated and then cooled to induce gelation.

3. The method of claim 2 wherein said portion comprises the collagenous protein source and is heated to at least 50 degrees C. and then cooled to a temperature below about 8 degrees C.

4. The method of claim 3 , wherein said heated collagenous protein source is cooled to a temperature below about 5 degrees ° C.

5. The method of claim 1 wherein the collagenous protein source comprises gelatin.

6. The method of claim 1 wherein the collagenous protein source comprises porcine gelatin.

7. The method of claim 1 wherein the anticoagulant-treated blood plasma comprises any of EDTA-treated, heparin-treated, or citrate-treated, blood plasma.

8. The method of claim 1 wherein the dermal cells comprises at least one of fibroblasts, and monocytes.

9. The method of claim 1 wherein the aqueous carrier comprises distilled water.

10. The method of claim 1 wherein the aqueous carrier comprises an isotonic saline solution; or phosphate buffered physiologic saline (PBS); or PBS with 4% formaldehyde; or PBS with cell culture medium; or cell culture medium.

11. The method of claim 1 wherein the mixture further comprises a dispersant.

12. The method of claim 11 , wherein said dispersant comprises an essential oil.

13. The method of claim 12 , wherein said essential oil comprises a cinnamon oil or a component thereof.

14. The method of claim 13 , wherein said cinnamon oil comprises cinnamaldehyde.

15. The method of claim 1 , wherein the method further comprises storing the gel for up to two weeks at refrigerator temperature following gelation.

16. The method of claim 1 , wherein the method further comprises

administering a test therapy to the composition; and

observing changes in the composition.

17. The method of claim 16 wherein the method further comprises incorporating a substance into the dermal-simulation composition.

18. The method of claim 17 wherein the substance comprises tattoo ink.

19. The method of claim 16 wherein the step of administering a test therapy further comprises administering at least one of cold plasma, electric energy and electro-kinetic energy.

20. The method of claim 16 wherein the step of observing changes further comprises at least one of physical, chemical, and optical measurement, and visual observation.

21. The method of claim 20 further comprises at one of transparency, transmittal, reflectivity and colorimetric measurement.

22. The method of claim 16 wherein the step of observing changes further comprises extracting a portion of the composition for analysis.

23. The method of claim 22 wherein the extracted portion is a central part of the sample.

Assignments (2)
CHANGE OF NAME Recorded Jun 23, 2022
From: CLEARIT LLC
To: CLEAR INTRADERMAL TECHNOLOGIES, INC.
Reel/Frame 060438/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2019
From: WINKELMAN, JAMES W.; SCHMIEG, MARTIN E.
To: CLEARIT, LLC
Reel/Frame 048051/0340 →
Continuity (2)
Provisional Application 62620313 · Jan 22, 2018
Related Publication 20200116704A1 · Apr 16, 2020